TABLE 3.
PFT-induced effects observed in vivo
| Pathogena | PFTa | Presence of PFT effect |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Innate immune responses |
Barrier dysfunction | Vasoconstriction and -dilation and altered blood pressure | Vascular and ischemic necrosis | Immune evasion |
Hijacking of host factors | Programmed cell death of nonimmune cells | |||||
| Inflammation | PRRs involved | Inflammasome activation | Cytotoxicity toward immune cells (direct and via programmed cell death) | Intracellular survival of pathogen | |||||||
| S. pneumoniae | PLY | × | × | × | × | × | × | × | |||
| GAS | SLO | × | × | × | × | × | × | ||||
| SLS | × | × | |||||||||
| GBS | β-h/c | × | × | × | × | ||||||
| S. aureus | PVL | × | × | × | |||||||
| Alpha-toxin | × | × | × | × | × | × | |||||
| γ-hemolysin | × | ||||||||||
| LukED | × | ||||||||||
| LukGH | × | ||||||||||
| B. anthracis | ALO | × | × | × | |||||||
| C. botulinum | BLY | × | |||||||||
| C. perfringens | β-toxin | × | × | × | |||||||
| ε-toxin | × | × | |||||||||
| PFO | × | × | |||||||||
| C. septicum | Alpha-toxin | × | |||||||||
| C. tetani | Tetanolysin | × | |||||||||
| L. monocytogenes | LLO | × | × | ||||||||
| M. tuberculosis | ESAT-6 | × | × | ||||||||
| E. coli | HlyA | × | × | × | × | ||||||
| V. cholerae | VCC | × | × | ||||||||
See Table 2 for details on these pathogens and PFTs.